Clinical characteristics and possible phenotypes of an adult severe asthma population

Imagem de Miniatura
Arquivos
art_CARVALHO-PINTO_Clinical_characteristics_and_possible_phenotypes_of_an_adult_2012.PDF (365.39 KB)
Citações na Scopus
57
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Autores
RABE, Klaus F.
Citação
RESPIRATORY MEDICINE, v.106, n.1, p.47-56, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Currently, there are no studies of well-characterized severe asthmatics in Brazil. We aimed to study a population of severe treated asthmatics still uncontrolled to characterize them and define possible phenotypes. Methods: Descriptive cross-sectional outpatient study of severe asthmatics, evaluating functional and inflammatory markers, health-related quality of life, anxiety and depression symptoms, clinical control status, and characteristics related to atopy, age of asthma onset, induced sputum eosinophil levels, and airflow limitation. We also grouped the subgroups characteristics to identify phenotypes. The study is registered on ClinicalTrial.gov NCT 01089322. Results: From 128 eligible patients with severe/uncontrolled asthma, 74 fulfilled the inclusion criteria. The cohort was comprised of 85% women, frequently with a body mass index higher than 31 kg m(-2), atopy (60%), early-onset disease (50%), sputum eosinophilia (80%), comorbidities, and reduced quality of life. Nonatopics had significant higher asthma onset (19 y.a.) and twice level of induced sputum eosinophil. Late-onset patients had significantly less atopy (57%) and higher levels of induced sputum eosinophils. Non-eosinophilics had lower levels of inflammatory markers. Patients with airflow limitation had more intensive care unit admissions (56%) and 1.5 times more airway resistance. Subgroups characteristics identified a priori four well-characterized phenotypes, with 55% presenting sputum eosinophilia. Conclusion: Our data emphasize the high burden of disease, the persistence of inflammation and the existence of clinical possible phenotypes population sharing common features with published cohorts. Despite the necessity of further investigation into pathogenic mechanisms, this study with clinically difficult patient group may help to improve future asthma care.
Palavras-chave
Asthma, Severe asthma, Characteristics, Atopy, Sputum eosinophils, Phenotypes
URI
https://observatorio.fm.usp.br/handle/OPI/1011
Referências
  1. Alves RS, 2008, J BRAS PNEUMOL, V34, P646
  2. Araujo Ana Carla Sousa de, 2007, J Bras Pneumol, V33, P495
  3. Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC
  4. BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
  5. Bousquet J, 2010, EUR RESPIR J, V36, P995, DOI 10.1183/09031936.00012610
  6. Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049
  7. Committee GE Committee GS, GLOB STRAT ASTHM MAN
  8. Cruz AA, 2009, ALLERGY, V64, P319, DOI 10.1111/j.1398-9995.2009.02026.x
  9. Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32
  10. Ferrer M, 2002, EUR RESPIR J, V19, P405, DOI 10.1183/09031936.02.00213202
  11. Franco R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-82
  12. Franco R, 2009, ALLERGY, V64, P478, DOI 10.1111/j.1398-9995.2009.01981.x
  13. Incalzi RA, 2001, CHEST, V120, P734, DOI 10.1378/chest.120.3.734
  14. JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890
  15. Leite Mylene, 2008, J Bras Pneumol, V34, P756
  16. Littner MR, 2005, CHEST, V128, P1128, DOI 10.1378/chest.128.3.1128
  17. Louis R, 2000, AM J RESP CRIT CARE, V161, P9
  18. Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
  19. Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041
  20. Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639
  21. Morris AH, 1984, CLIN PULMONARY FUNCT
  22. Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008
  23. Nishimura K, 2004, J ASTHMA, V41, P57, DOI 10.1081/JAS-120024596
  24. Oppenheimer J, 2006, ANN ALLERG ASTHMA IM, V96, pS6
  25. Pavord ID, 1997, THORAX, V52, P498
  26. Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308
  27. Ponte Eduardo, 2007, J Bras Pneumol, V33, P15
  28. Quanjer P H, 1993, Eur Respir J Suppl, V16, P5
  29. Robinson DS, 2003, EUR RESPIR J, V22, P478, DOI 10.1183/09031936.03.00017003
  30. Sant'Anna Claudia Adriana, 2003, Chest, V123, P136, DOI 10.1378/chest.123.1.136
  31. Santos Pde M, 2008, J BRAS PNEUMOL, V34, P995
  32. Santos UP, 2001, J PNEUMOL, V27, P231
  33. Sembajwe G, 2010, EUR RESPIR J, V35, P279, DOI 10.1183/09031936.00027509
  34. Silkoff PE, 2005, J ALLERGY CLIN IMMUN, V116, P1249, DOI 10.1016/j.jaci.2005.09.029
  35. Souza-Machado C, 2010, EUR RESPIR J, V35, P515, DOI 10.1183/09031936.00101009
  36. Spielberger CD, 1983, MANUAL STATE TRAIT A
  37. Stelmach R, 2005, CHEST, V128, P3140, DOI 10.1378/chest.128.5.3140
  38. Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504
  39. ten Brinke A, 2001, AM J RESP CRIT CARE, V164, P744
  40. ten Brinke A, 2001, J ALLERGY CLIN IMMUN, V107, P449, DOI 10.1067/mai.2001.113047
  41. ten Brinke A, 2004, AM J RESP CRIT CARE, V170, P601, DOI 10.1164/rccm.200404-440OC
  42. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma, 2003, EUR RESP J, V22, P470
  43. [Anonymous], 2005, AM J RESP CRIT CARE, V171, P912

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/05